Back to search
Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This phase II trial tests how well tafasitamab and rituximab work for front-line treatment of patients with post-transplant lymphoproliferative disorder. Post-t…
This phase Ib trial tests the safety and effectiveness of epcoritamab in treating patients with post-transplant lymphoproliferative disorder (PTLD) that has com…